StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Veru, Inc. (VERU) Climbs 11%, Covid Treatment to Face FDA Panel on Oct. 6
September 7, 2022 9:17 AM
Veru, Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Momentum Movers
Trader Talk